A retrospective analysis of clinical outcomes between hospitalized patients with COVID-19 who received famotidine or pantoprazole
Description
CONCLUSIONS: Famotidine is associated with lower odds for all-cause mortality, mechanical ventilation, vasopressor use, acute kidney injury, and gastrointestinal bleeding as compared to pantoprazole in patients hospitalized with COVID-19. We